Endocannabinoid regulation in human endometrium across the menstrual cycle

Reproductive Sciences

Volumn 22, Issue 1, 2015, Pages 113-123

  Scotchie, Jessica G ^a   Savaris, Ricardo F ^b   Martin, Caitlin E ^b   Young, Steven L ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

cyclooxygenase 2; diacylglycerol lipase; endometrium; fatty acid amide hydrolase; monoacylglycerol lipase

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ACYLGLYCEROL LIPASE; ANANDAMIDE; CYCLOOXYGENASE 2; DIACYLGLYCEROL LIPASE ALPHA; DIACYLGLYCEROL LIPASE BETA; FATTY ACID AMIDASE; MESSENGER RNA; N ARACHIDONYL PHOSPHATIDYLETHANOLAMINE PHOSPHOLIPASE D; OXIDOREDUCTASE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPASE D; UNCLASSIFIED DRUG; ACYLGLYCEROL; AMIDASE; AMIDE; ARACHIDONIC ACID DERIVATIVE; DIACYLGLYCEROL LIPASE ALPHA, HUMAN; DIACYLGLYCEROL LIPASE BETA, HUMAN; ENDOCANNABINOID; FATTY-ACID AMIDE HYDROLASE; GLYCERYL 2-ARACHIDONATE; LIPOPROTEIN LIPASE; NAPEPLD PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN;

ARTICLE; ENDOMETRIUM; ENZYME DEGRADATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; MENSTRUAL CYCLE; NORMAL HUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

AMIDOHYDROLASES; ARACHIDONIC ACIDS; CYCLOOXYGENASE 2; ENDOCANNABINOIDS; ENDOMETRIUM; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCERIDES; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOPROTEIN LIPASE; MENSTRUAL CYCLE; MONOACYLGLYCEROL LIPASES; PHOSPHOLIPASE D; POLYUNSATURATED ALKAMIDES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84919695406     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719114533730     Document Type: Article

References (49)

1. Alexander A, Smith P, Rosengren R. Cannabinoids in the treatment of cancer. Cancer Lett. 2009 ; 285 ((1)). 6-12
2. Gaoni Y, Mechoulam R. Isolation, structure, and partial synthesis of an active constituent of hashish. J Am Chem Soc. 1964 ; 86 ((8)). 1646-1647
3. Mendelson J, Mello N, Ellingboe J, Skupny A, Lex B, Griffin M. Marihuana smoking suppresses luteinizing hormone in women. J Pharmacol Exp Ther. 1986 ; 237 ((3)). 862-866
4. Gibson G, Baghurst P, Colley D. Maternal alcohol, tobacco and cannabis consumption and the outcome of pregnancy. Aust N Z J Obstet Gynaecol. 1983 ; 23 ((1)). 15-19
5. Frank D, Bauchner H, Parker S. Neonatal body proportionality and body composition after in utero exposure to cocaine and marijuana. J Pediatr. 1990 ; 117 ((4)). 622-626
6. Sherwood R, Keating J, Kavvadia V, Greenough A, Peters T. Substance misuse in early pregnancy and relationship to fetal outcome. Eur J Pediatr. 1999 ; 158 ((6)). 488-492
7. Mouslech Z, Valla V. Endocannabinoid system: an overview of its potential in current medical practice. Neuro Endocrinol Lett. 2009 ; 30 ((2)). 153-179
8. Natarajan V, Schmid P, Reddy P, Schmid H. Catabolism of n-acylethanolamine phospholipids by dog brain preparations. J Neurochem. 1984 ; 42 ((6)). 1613-1619
9. Cravatt B, Giang D, Mayfield S, Boger D, Lerner R, Gilula N. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature. 1996 ; 384 ((6604)). 83-87
10. Cravatt B, Lichtman A. The enzymatic inactivation of the fatty acid amide class of signaling lipids. Chem Phys Lipids. 2002 ; 121 ((1-2)). 135-148
11. Pacher P, Kunos G. Modulating the endocannabinoid system in human health and disease - successes and failures. FEBS J. 2013 ; 280 ((9)). 1918-1943
12. Di Blasio AM, Vignali M, Gentilini D. The endocannabinoid pathway and the female reproductive organs. J Mol Endocrinol. 2013 ; 50 ((1)). R1 - R9
13. Sun X, Dey S. Cannabinoid/endocannabinoid signaling impact on early pregnancy events. Curr Top Behav Neurosci. 2009 ; 1: 255-273
14. Wang H, Xie H, Sun X. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation. Prostaglandins Other Lipid Mediat. 2007 ; 83 ((1-2)). 62-74
15. Maccarrone M, Defelici M, Klinger F. Mouse blastocysts release a lipid which activates anandamide hydrolase in intact uterus. Mol Hum Reprod. 2004 ; 10 ((4)). 215-221
16. Wang H, Xie H, Guo Y. Fatty acid amide hydrolase deficiency limits early pregnancy events. J Clin Invest. 2006 ; 116 ((8)). 2122-2131
17. Paria B, Song H, Wang X. Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation. J Biol Chem. 2001 ; 276 ((23)). 20523-20528
18. Maccarrone M, Valensise H, Bari M, Lazzarin N, Romanini C, Finazzi-Agro A. Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage. Lancet. 2000 ; 355 ((9212)). 1326-1329
19. Maccarrone M, Valensise H, Bari M, Lazzarin N, Romanini C, Finazzi-Agro A. Progesterone up-regulates anandamide hydrolase in human lymphocytes: Role of cytokines and implications for fertility. J Immunol. 2001 ; 166 ((12)). 7183-7189
20. Maccarrone M, Bisogno T, Valensise H. Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after ivf and embryo transfer. Mol Hum Reprod. 2002 ; 8 ((2)). 188-195
21. Habayeb O, Taylor A, Finney M, Evans M, Konje J. Plasma anandamide concentration and pregnancy outcome in women with threatened miscarriage. JAMA. 2008 ; 299 ((10)). 1135-1136
22. Taylor A, Abbas M, Habiba M, Konje J. Histomorphometric evaluation of cannabinoid receptor and anandamide modulating enzyme expression in the human endometrium through the menstrual cycle. Histochem Cell Biol. 2010 ; 133 ((5)). 557-565
23. Andersen C, Jensen J, Orntoft T. Normalization of real-time quantitative reverse transcription-pcr data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004 ; 64 ((15)). 5245-5250
24. Plante B, Lessey B, Taylor R. G protein-coupled estrogen receptor (gper) expression in normal and abnormal endometrium. Reprod Sci. 2012 ; 19 ((7)). 684-693
25. Budwit-Novotny DA, Mccarty K, Cox E. Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res. 1986 ; 46 ((10)). 5419-5425
26. Fuhrich D, Lessey B, Savaris R. Comparison of hscore assessment of endometrial beta3 integrin subunit expression with digital hscore using computerized image analysis (imagej). Anal Quant Cytol Histol. 2013 ; 35 ((4)). 210-216
27. Blitek A, Waclawik A, Kaczmarek M, Stadejek T, Pejsak Z, Ziecik A. Expression of cyclooxygenase-1 and -2 in the porcine endometrium during the oestrous cycle and early pregnancy. Reprod Domest Anim. 2006 ; 41 ((3)). 251-257
28. Gebeh A, Marczylo E, Amoako A, Willets J, Konje J. Variation in stability of endogenous reference genes in fallopian tubes and endometrium from healthy and ectopic pregnant women. Int J Mol Sci. 2012 ; 13 ((3)). 2810-2826
29. Vogel C, Marcotte E. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet. 2012 ; 13 ((4)). 227-232
30. Maia HJ, Haddad C, Pinheiro N, Casoy J. The effect of oral contraceptives on aromatase and cox-2 expression in the endometrium of patients with idiopathic menorrhagia or adenomyosis. Int J Womens Health. 2013 ; 5: 293-299
31. Smith O, Jabbour H, Critchley H. Cyclooxygenase enzyme expression and e series prostaglandin receptor signalling are enhanced in heavy menstruation. Hum Reprod. 2007 ; 22 ((5)). 1450-1456
32. Koike H, Ikenoue T, Mori N. [Studies on prostaglandin production relating to the mechanism of dysmenorrhea in endometriosis]. Nihon Naibunpi Gakkai Zasshi. 1994 ; 70 ((1)). 43-56
33. Brady P, Stanic A, Styer A. Uterine fibroids and subfertility: an update on the role of myomectomy. Curr Opin Obstet Gynecol. 2013 ; 25 ((3)). 255-259
34. Fertil Steril. 2012: 302-307.
35. Melford S, Taylor A, Konje J. Of mice and (wo)men: factors influencing successful implantation including endocannabinoids. Hum Reprod Update. 2014 ; 20 ((3)). 415-428
36. Baek J, Darlington C, Smith P, Ashton J. Antibody testing for brain immunohistochemistry: brain immunolabeling for the cannabinoid cb(2) receptor. J Neurosci Methods. 2013 ; 216 ((2)). 87-95
37. Marions L, Danielsson K. Expression of cyclo-oxygenase in human endometrium during the implantation period. Mol Hum Reprod. 1999 ; 5 ((10)). 961-965
38. Tokyol C, Aktepe F, Dilek F, Sahin O, Arioz D. Expression of cyclooxygenase-2 and matrix metalloproteinase-2 in adenomyosis and endometrial polyps and its correlation with angiogenesis. Int J Gynecol Pathol. 2009 ; 28 ((2)). 148-156
39. Jones R, Kelly R, Critchley H. Chemokine and cyclooxygenase-2 expression in human endometrium coincides with leukocyte accumulation. Hum Reprod. 1997 ; 12 ((6)). 1300-1306
40. Stavreus-Evers A, Koraen L, Scott J, Zhang P, Westlund P. Distribution of cyclooxygenase-1, cyclooxygenase-2, and cytosolic phospholipase a2 in the luteal phase human endometrium and ovary. Fertil Steril. 2005 ; 83 ((1)). 156-162
41. Smith G, Roberts R, Hall C, Nuki G. Reversible ovulatory failure associated with the development of luteinized unruptured follicles in women with inflammatory arthritis taking non-steroidal anti-inflammatory drugs. Br J Rheumatol. 1996 ; 35 ((5)). 458-462
42. Diao H, Zhu H, Ma H. Rat ovulation, implantation and decidualization are severely compromised by cox-2 inhibitors. Front Biosci. 2007 ; 12: 3333-3342
43. Lim H, Paria B, Das S. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell. 1997 ; 91 ((2)). 197-208
44. Nakhai-Pour HR, Broy P, Sheehy O, Berard A. Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion. CMAJ. 2011 ; 183 ((15)). 1713-1720
45. Li D, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: Population based cohort study. BMJ. 2003 ; 327 ((7411)). 368
46. Nielsen G, Sorensen H, Larsen H, Pedersen L. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ. 2001 ; 322 ((7281)). 266-270
47. Keim S, Klebanoff M. Aspirin use and miscarriage risk. Epidemiology. 2006 ; 17 ((4)). 435-439
48. El-Talatini MR, Taylor A, Konje J. The relationship between plasma levels of the endocannabinoid, anandamide, sex steroids, and gonadotrophins during the menstrual cycle. Fertil Steril. 2010 ; 93 ((6)). 1989-1996
49. Trabucco E, Acone G, Marenna A. Endocannabinoid system in first trimester placenta: low FAAH and high cb1 expression characterize spontaneous miscarriage. Placenta. 2009 ; 30 (6). 516-522